Shares of Salt Lake City-based analytics vendor Health Catalyst began trading on NASDAQ on Thursday. The initial public offering had been a long time coming.
Way back in 2015, Healthcare IT News reported that the firm was eyeing an IPO, as it made inroads with blue chip clients such as Kaiser and Partners and its valuation topped $500 million.
Since then, Health Catalyst’s growth has only continued. By early this year, the company had doubled that number – becoming a new healthcare unicorn valued at more than $1 billion, after a new funding round of $100 million.
MORE: A month after going public, Health Catalyst reports 60% revenue growth in Q2